Formulary Chapter 1: Gastro-intestinal system - Full Section
|
Notes:
Unless explicitly stated, any brand names included in brackets next to a drug's generic name are there solely to aid searching and identification, and should not be considered to limit use to that specific brand. |
Useful Links |
NHSE: Conditions for which over the counter items should not routinely be prescribed in primary care: |
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
|
01.01 |
Dyspepsia and gastro-oesophageal reflux disease (0,0)
|
|

Dyspepsia (0,0)
|
|

Gastro-oesophageal reflux disease (0,0)
|
01.01.01 |
Antacids and simeticone (0,0)
|
|

Aluminium and magnesium containing antacids (0,0)
|
|

Aluminium-magnesium complexes (0,0)
|
|

Antacid preparations containing simeticone (0,0)
|
|

Simeticine alone
(1,0)
|
|

Antacid preparations containing dimeticone or local anaesthetics (0,0)
|
01.01.02 |
Compound alginates and proprietary indigestion preparations (0,0)
|
|

Compound alginate preparations
(5,0)
|
01.02 |
Antispasmodics and other drugs altering gut motility
(1,0)
|
|

Antimuscarinics
(1,1)
|
|

Other antispasmodics
(4,0)
|
|

Motility stimulants (0,0)
|
01.03 |
Antisecretory drugs and mucosal protectants (0,0)
|
|

Helicobacter pylori infection (0,0)
|
|

NSAID-associated ulcers (0,0)
|
01.03.01 |
H2-receptor antagonists
(2,0)
|
01.03.02 |
Selective antimuscarinics (0,0)
|
01.03.03 |
Chelates and complexes
(2,0)
|
01.03.04 |
Prostaglandin analogues (0,0)
|
01.03.05 |
Proton pump inhibitors (PPIs)
(6,0)
|
01.03.06 |
Other ulcer-healing drugs (0,0)
|
01.04 |
Acute diarrhoea (0,0)
|
01.04.01 |
Adsorbents and bulk-forming drugs (0,0)
|
01.04.02 |
Antimotility drugs
(3,0)
|
01.05 |
Chronic bowel disorders (0,0)
|
|

Irritable bowel syndrome (0,0)
|
|

Malabsorption syndromes (0,0)
|
|

Inflammatory bowel disease (0,0)
|
|

Antibiotic-associated colitis (0,0)
|
|

Diverticular disease (0,0)
|
|

Aminosalicylates
(1,0)
|
|

Corticosteroids (0,0)
|
|

Food allergy (0,0)
|
|

Cytokine inhibitors (0,0)
|
|

Food Allergy (0,0)
|
01.05.01 |
Aminosalicylates
(2,0)
|
01.05.02 |
Corticosteroids
(4,0)
|
01.05.03 |
Drugs affecting the immune response
(7,0)
|
|

Cytokine inhibitors
(3,0)
|
01.05.04 |
(0,0)
|
01.06 |
Laxatives (0,0)
|
01.06.01 |
Bulk-forming laxatives
(2,0)
|
01.06.02 |
Stimulant laxatives
(7,0)
|
|

Other Stimulant laxatives (0,0)
|
01.06.03 |
Faecal softeners
(1,0)
|
01.06.04 |
Osmotic laxatives
(4,0)
|
01.06.05 |
Bowel cleansing preparations
(3,0)
|
01.06.06 |
Peripheral opiod-receptor antagonist
(2,0)
|
01.06.07 |
5HT4 receptor agonists
(2,0)
|
01.07 |
Local preparations for anal and rectal disorders (0,0)
|
01.07.01 |
Soothing haemorrhoidal preparations
(1,0)
|
01.07.02 |
Compound haemorrhoidal preparations with corticosteroids
(3,0)
|
01.07.03 |
Rectal sclerosants
(1,0)
|
01.07.04 |
Management of anal fissures
(3,0)
|
01.08 |
Stoma care
(1,0)
|
01.09 |
Drugs affecting intestinal secretions (0,0)
|
01.09.01 |
Drugs affecting biliary composition and flow
(2,0)
|
|

Other prepatations for biliary disorders (0,0)
|
01.09.02 |
Bile acid sequestrants
(1,0)
|
01.09.03 |
Aprotinin (0,0)
|
01.09.04 |
Pancreatin
(1,1)
|